Clinical Education and Resources
These educational resources are provided to you through partnerships with other educational organizations and are not AVAHO-developed education.
Project VA-ECHO
What is VA-ECHO?
Specialty Care Veterans Administration Extension for Community Healthcare Outcomes (VA-ECHO) is a national accredited continuing education program.
- VA-ECHO cultivates a learning community through mentorship by promoting
evidence-based, Veteran-centered, and team-based care in more than 25
specialties. - Our program offers a wide variety of accredited continuing education (CE) credits
options (up to 18 types) including, but not limited to: AAPA, ACCME, ACCME-NP,
ACPE, ANCC, ASWB, NYSEDSW, & JA-IPCE.
SharePoint Page:
Specialty Care VA-ECHO - Home (sharepoint.com)
Individuals can join our Listserv(s) here:
Clinical Pathways
The National Oncology Program Office has developed disease-specific Clinical Pathway tools for clinicians to use that map out evidence-based treatment courses.
These clinical support tools provide clinicians with guidance that ensure standardized, high-quality care for our Veterans living with a cancer diagnosis.
- The pathways were developed by a team of multidisciplinary subject matter experts and national guidelines: offering guidance for both common and rare cancers.
- The pathways differ from other national guidelines, as they take into consideration treatment efficacy, toxicity, and cost.
- Use of the pathways also ensures access and equality of care, no matter where the receives cancer care.
Visit the VA Clinical Pathways page for more information.
Ongoing Opportunities
The following opportunities are available at your convenience (see dates for start/end availability).
Bladder Cancer: Assessing and Incorporating Novel Treatment Strategies (a Prime partner opportunity)
0.5 CME/CE
Available through January 11, 2025
Navigating the Evolving Treatment Paradigm for Myelodysplastic Syndromes and Myeloproliferative Neop (a Prime partner opportunity)
1.0 CME/CE
Available through October 24, 2024
Elevating Care Coordination for Timely Management of Follicular Lymphoma (a Prime Partner opportunity)
0.5 CME/CE
Available through December 20, 2024
Hepatobiliary Cancers: Real-World Appraoches for Improving Multi-disciplinary Care (a Prime partner opportunity)
0.5 CME/CE
Available through December 14, 2024
Accelerating Adoption of Novel Therapies for Optimal Diffuse Large B-Cell Lymphoma Care (a Prime partner opportunity)
1.0 CME/CE
Available through December 13, 2024
Expanding Access to Novel Treatment Approaches for Multiple Myeloma (a Prime partner opportunity)
1.0 CME/CE
Available through November 21, 2024